[Psoriatic arthritis : Overview of drug therapy options and administration characteristics].
Psoriatic arthritis is a chronic inflammatory disease of the musculoskeletal system with association to skin psoriasis and is characterized by variable clinical symptoms with very heterogeneous degrees of disease suffering for patients. Clinical manifestations essentially include alterations to the skin and nails, peripheral arthritis, enthesitis, dactylitis and/or spinal involvement. This variability necessitates an individualized therapy of patients with different therapy targets. Apart from international guidelines no therapy recommendations are available in Germany for treatment of psoriatic arthritis. For this reason this article summarizes the established points, characteristics and aspects to be considered in the therapy of psoriatic arthritis in Germany, taking the various main forms of the disease into consideration.
CIRI/Rheumatologie und Fraunhofer IME, Translationale Medizin und Pharmakologie, Universitätsklinikum Goethe Universität Frankfurt, Frankfurt am Main, Deutschland.
F
F
Behrens
Exzellenzzentrum Entzündungsmedizin, UKSH - Campus Lübeck, Lübeck, Deutschland.
D
D
Thaçi
Klinik für Rheumatologie und klinische Immunologie, Schön Klinik Hamburg Eilbek, Dehnhaide 120, 22081, Hamburg, Deutschland. JWollenhaupt@schoen-kliniken.de.
J
J
Wollenhaupt
Internistisch-rheumatologische Praxis, München, Deutschland.
K
K
Krüger
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D015535:Arthritis, Psoriatic / Q000175:diagnosis* / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents
Dactylitis; Disease activity; Enthesitis; Joints; Musculoskeletal system